{
    "URL": "https://doi.org/10.1371/journal.pntd.0009258",
    "Published": "March 12, 2021",
    "Subject_Areas": [
        "Antibodies",
        "Dengue virus",
        "Vaccine development",
        "Vaccines",
        "Dengue fever",
        "Viral vaccines",
        "Enzyme-linked immunoassays",
        "Vaccination and immunization"
    ],
    "Authors": {
        "Laura J. White": [
            "Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States of America"
        ],
        "Ellen F. Young": [
            "Department of Epidemiology, The University of North Carolina at Chapel Hill School of Public Health, Chapel Hill, NC, United States of America"
        ],
        "Mark J. Stoops": [
            "Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States of America"
        ],
        "Sandra R. Henein": [
            "Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States of America"
        ],
        "Elizabeth C. Adams": [
            "Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States of America"
        ],
        "Ralph S. Baric": [
            "Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States of America",
            "Department of Epidemiology, The University of North Carolina at Chapel Hill School of Public Health, Chapel Hill, NC, United States of America"
        ],
        "Aravinda M. de Silva": [
            "Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States of America"
        ]
    }
}